Masumoto H, Ohta S, Hirobe M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Drug Metab Dispos. 1991 Jul-Aug;19(4):768-80.
Oxidations of the piperidine ring by chemical model and liver microsomal systems were investigated with a simple piperidine derivative, N-benzylpiperidine (BP) (3), as the substrate in order to probe the generality and the mechanism of the biotransformation of the piperidine ring. The piperidine ring of BP (3) as well as that of phencyclidine (1) was suggested to be oxidized to a ketone at the beta-position in the meso-tetraphenylporphinatoiron(III) chloride system, and the reaction was expected to occur in the liver microsomal system. The beta-oxo formation was observed directly in the liver microsomal system, and found to be dependent on cytochrome P-450. Then it was suggested that the piperidine-beta-oxo formation was a general oxidation pathway of the piperidine biotransformation. Hydrogen abstraction in the reaction was not a rate-determining step. Therefore, we presumed a possible mechanism of beta-oxo formation via BP-iminium (21). From the comparative study on the reactivities of dipropylbenzylamine (DPB) (18) and BP (3), and the stabilities of iminium (Im+) species of BP (3) and DPB (18), it was suggested that BP-Im+ (21) was relatively stable and was the most likely precursor of BP-beta-oxo (6). BP-Im+ (21) and its free base, enamine (29), afforded large amounts of BP-beta-oxo as well as BP-alpha-oxo (9) in the chemical model and the microsomal systems. This evidence supported the iminium-enamine mechanism expressed as scheme III.
以一种简单的哌啶衍生物N-苄基哌啶(BP)(3)为底物,通过化学模型和肝微粒体系统研究了哌啶环的氧化反应,以探究哌啶环生物转化的普遍性和机制。在氯化中-四苯基卟吩铁(III)体系中,BP(3)的哌啶环以及苯环己哌啶(1)的哌啶环被认为在β位氧化成酮,并且预计该反应会在肝微粒体系统中发生。在肝微粒体系统中直接观察到了β-氧代物的形成,并且发现其依赖于细胞色素P-450。因此,有人提出哌啶-β-氧代物的形成是哌啶生物转化的一般氧化途径。反应中的氢提取不是速率决定步骤。因此,我们推测了通过BP-亚胺鎓(21)形成β-氧代物的可能机制。通过对二丙基苄胺(DPB)(18)和BP(3)反应活性以及BP(3)和DPB(18)亚胺鎓(Im+)物种稳定性的比较研究,表明BP-Im+(21)相对稳定,是BP-β-氧代物(6)最可能的前体。在化学模型和微粒体系统中,BP-Im+(21)及其游离碱烯胺(29)生成了大量的BP-β-氧代物以及BP-α-氧代物(9)。这一证据支持了方案III所示的亚胺鎓-烯胺机制。